---
figid: PMC5223135__nutd201649f4
figlink: /pmc/articles/PMC5223135/figure/fig4/
number: F4
caption: Proposed mechanisms of kefir peptides-mediated modulation of the lipid metabolism
  pathway in 30% fructose-induced NAFLD mice. (a) High-dose fructose consumption resulted
  in leptin resistance, increasing the expression of LepR (OB-R) and SOCS-3 and blocking
  of the leptin signal. (b) The administration of kefir peptides reduced leptin resistance
  and activated JAK2 signal transduction through JAK2/STAT3 and JAK2/AMPK pathways
  to improve the NAFLD syndrome in the fructose-induced fatty liver disease model.
pmcid: PMC5223135
papertitle: Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic
  fatty liver disease in a murine model by modulation of inflammation and the JAK2
  signaling pathway.
reftext: H L Chen, et al. Nutr Diabetes. 2016 Dec;6(12):e237.
pmc_ranked_result_index: '15365'
pathway_score: 0.9668717
filename: nutd201649f4.jpg
figtitle: Proposed mechanisms of kefir peptides-mediated modulation of the lipid metabolism
  pathway in 30% fructose-induced NAFLD mice
year: '2016'
organisms: Homo sapiens
ndex: fc85283f-dea0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5223135__nutd201649f4.html
  '@type': Dataset
  description: Proposed mechanisms of kefir peptides-mediated modulation of the lipid
    metabolism pathway in 30% fructose-induced NAFLD mice. (a) High-dose fructose
    consumption resulted in leptin resistance, increasing the expression of LepR (OB-R)
    and SOCS-3 and blocking of the leptin signal. (b) The administration of kefir
    peptides reduced leptin resistance and activated JAK2 signal transduction through
    JAK2/STAT3 and JAK2/AMPK pathways to improve the NAFLD syndrome in the fructose-induced
    fatty liver disease model.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK2
  - LEPR
  - TG
  - PRKAG3
  - SOCS3
  - CHPT1
  - ACACA
  - PRKAG1
  - STAT3
  - SREBF1
  - PRKAB2
  - PRKAB1
  - PRKAA1
  - PRKAG2
  - ACACB
  - PRKAA2
  - Fatty acid
  - fructose
genes:
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: OB-R
  symbol: OBR
  source: hgnc_alias_symbol
  hgnc_symbol: LEPR
  entrez: '3953'
- word: TG
  symbol: TG
  source: hgnc_symbol
  hgnc_symbol: TG
  entrez: '7038'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: SOCS3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: CPT-1
  symbol: CPT1
  source: hgnc_alias_symbol
  hgnc_symbol: CHPT1
  entrez: '56994'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: SREBP1-C
  symbol: SREBP-1c
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
chemicals:
- word: Fatty acid
  source: MESH
  identifier: D005227
- word: fructose
  source: MESH
  identifier: D005632
diseases: []
figid_alias: PMC5223135__F4
redirect_from: /figures/PMC5223135__F4
figtype: Figure
---
